Valuation: Conavi Medical Corp.

Market Cap 22.08M 15.76M 13.74M 12.98M 11.78M 1.51B 22.17M 155M 59.99M 769M 59.21M 57.89M 2.47B P/E 2024 *
-
P/E 2025 -1.88x
Enterprise Value 36.14M 25.8M 22.5M 21.24M 19.29M 2.48B 36.29M 254M 98.2M 1.26B 96.92M 94.77M 4.05B EV / Sales 2024 *
-
EV / Sales 2025 7.18x
Free-Float
66.52%
Yield 2024 *
-
Yield 2025 -
1 day+0.90%
1 week-4.49%
Current month-4.88%
1 month-14.70%
3 months-31.97%
6 months-59.80%
Current year-65.23%
1 week 0.1
Extreme 0.104
0.12
1 month 0.1
Extreme 0.1007
0.16
Current year 0.1
Extreme 0.1007
0.43
1 year 0.1
Extreme 0.1007
0.56
3 years 0
Extreme 0.0007
1
5 years 0
Extreme 0.0007
1
10 years 0
Extreme 0.0007
1
Change 5-day change 1-year change 3-year change Capi.($)
+0.90%-4.49% - - 15.76M
-1.04%+6.83%+35.84%+28.05% 241B
-0.32%+5.83%+9.58%-17.01% 149B
+2.55%+6.55%-10.35%+31.26% 139B
-0.48%+0.84%-55.70%-18.27% 62.81B
+0.01%+4.61%+18.61%+20.87% 50.87B
-1.69%-1.20%-19.89%-15.39% 48.21B
+0.08%+6.49%+23.87%+39.32% 44.11B
-1.88%+3.25%+40.14%+53.16% 41.42B
-2.27%+16.07%+133.21%+70.51% 36.18B
Average -0.41%+6.42%+19.48%+21.39% 90.26B
Weighted average by Cap. -0.26%+6.14%+15.57%+17.51%

Financials

2024 2025
Net sales 2.16M 1.54M 1.35M 1.27M 1.15M 148M 2.17M 15.21M 5.87M 75.26M 5.79M 5.67M 242M 9.12M 6.51M 5.68M 5.36M 4.87M 625M 9.16M 64.22M 24.78M 318M 24.46M 23.92M 1.02B
Net income -43.62M -31.13M -27.15M -25.64M -23.28M -2.99B -43.8M -307M -118M -1.52B -117M -114M -4.89B -20.52M -14.65M -12.77M -12.06M -10.95M -1.41B -20.6M -144M -55.74M -714M -55.02M -53.79M -2.3B
Net Debt 82.74M 59.06M 51.5M 48.63M 44.16M 5.67B 83.09M 583M 225M 2.88B 222M 217M 9.27B 14.06M 10.04M 8.76M 8.27M 7.51M 963M 14.12M 99.03M 38.21M 490M 37.72M 36.88M 1.58B
Logo Conavi Medical Corp.
Conavi Medical Corp. is a Canada-based medical device company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary interventions (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.
Employees
-
Date Price Change Volume
26-09-18 US$0.1149 +0.90% 10,441
26-09-17 US$0.1139 +9.52% 189,624
26-09-16 US$0.1040 -8.85% 63,413
26-09-15 US$0.1141 -5.15% 112,031
26-09-11 US$0.1203 +3.71% 7,281

Annual profits - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!